FMA
CO

FNY Managed Accounts’s Global Cord Blood Corporation CO Stock Holding History

FNY Managed Accounts’s Portfolio CO Stock Details CO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-350
Closed -$3K – 733
2017
Q2 		$3K Buy
+350
New +$2.79K 0.03% 160

Other funds holding CO

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
PM
Parametrica Management Wanchai, Hong Kong $88M AUM 48.84% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return

FNY Managed Accounts's CO Position: Q3 2017 in Review

FNY Managed Accounts sold out of Global Cord Blood Corporation (CO) in Q3 2017, closing a stake of 350 shares — an estimated $3K sold.

FNY Managed Accounts first reported a position in CO in Q2 2017 and held it in 1 quarter. The position peaked at $3K in Q2 2017. 52 funds tracked by Wall St. Rank hold CO as of Q3 2017.

  • FNY Managed Accounts reported no remaining Global Cord Blood Corporation position as of Q3 2017 after selling out during the quarter.
  • FNY Managed Accounts sold 350 Global Cord Blood Corporation shares in Q3 2017, an estimated $3K.
  • FNY Managed Accounts first reported a position in Global Cord Blood Corporation in Q2 2017 and held it in 1 quarter.
  • FNY Managed Accounts's Global Cord Blood Corporation position peaked at $3K in Q2 2017.
  • 52 funds tracked by Wall St. Rank held Global Cord Blood Corporation as of Q3 2017.

Based on FNY Managed Accounts's 13F filing for Q3 2017, filed 9 Nov 2017.